+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anatomic Pathology Testing Market by Test Type (Digital Pathology, Hematoxylin And Eosin Staining, Immunohistochemistry), Sample Type (Cytology Samples, Frozen Sections, Tissue Biopsy), Application, End User - Global Forecast 2025-2030- Product Image
Anatomic Pathology Testing Market by Test Type (Digital Pathology, Hematoxylin And Eosin Staining, Immunohistochemistry), Sample Type (Cytology Samples, Frozen Sections, Tissue Biopsy), Application, End User - Global Forecast 2025-2030- Product Image
Sale

Anatomic Pathology Testing Market by Test Type (Digital Pathology, Hematoxylin And Eosin Staining, Immunohistochemistry), Sample Type (Cytology Samples, Frozen Sections, Tissue Biopsy), Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904684
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Anatomic pathology testing is central to diagnostic precision and the advancement of patient care in healthcare environments. With the sector undergoing profound change due to evolving clinical requirements and ongoing digital transformation, actionable analysis is essential for senior leadership to drive operational excellence and strategic growth.

Market Snapshot: Anatomic Pathology Testing Market Overview

The Anatomic Pathology Testing Market grew from USD 45.03 billion in 2024 to USD 47.92 billion in 2025. It is expected to continue growing at a CAGR of 6.24%, reaching USD 64.78 billion by 2030.

Scope & Segmentation

This report extensively assesses the anatomic pathology testing ecosystem, addressing critical market segmentation by product, application, and end user, as well as regional trends and technology adoption.

  • Test Types: Digital pathology (image analysis software, slide scanners), hematoxylin and eosin staining, immunohistochemistry (monoclonal and polyclonal antibodies), molecular pathology (fluorescence in situ hybridization, next generation sequencing, polymerase chain reaction), and specialized stains (periodic acid-Schiff, silver, trichrome).
  • Sample Types: Cytology samples, frozen sections, tissue biopsies.
  • Applications: Genetic disorders (chromosomal and single gene), infectious diseases (bacterial, viral), oncology (breast, lung, prostate cancers).
  • End Users: Diagnostic laboratories, hospitals, research institutes.
  • Regional Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, South Africa, Saudi Arabia, and others), and Asia-Pacific (including China, India, Japan, Australia, and additional countries).
  • Companies Profiled: Leading industry operators and reference laboratories with a global and regional footprint.

Key Takeaways for Senior Decision-Makers

  • Advanced digitalization and integration of AI have redefined slide analysis speed and consistency, empowering pathologists to deliver insights remotely and collaboratively.
  • Adoption of molecular pathology techniques, such as next generation sequencing, enhances disease mechanism understanding, supporting precision therapy and comprehensive disease profiling.
  • Emergence of multidisciplinary diagnostic workflows, combining laboratory results with molecular and clinical data, facilitates improved patient management and targeted interventions.
  • Decentralized and cloud-based telepathology models are gaining ground, providing scalable solutions amidst changing regulatory and public health landscapes.
  • Market leaders are prioritizing partnerships, M&A, and agile R&D roadmaps to align with evolving test requirements and drive product innovation.
  • Strategic responses to supply chain and reimbursement challenges are crucial to optimize cost efficiency and maintain service excellence.

Tariff Impact on Anatomic Pathology Testing Market

United States tariff adjustments are reshaping procurement and vendor management strategies. Laboratories are increasing local sourcing and supplier diversification in anticipation of higher costs for diagnostic instruments and reagents. These shifts highlight the need for resilient inventory management and may accelerate consolidation as smaller entities seek advantages through scale or robust networks. Cross-border collaborations could face limitations in flexibility, motivating adoption of open and modular platforms to support innovation and continuity.

Methodology & Data Sources

This report leverages a layered research process, featuring in-depth secondary data review and extensive primary interviews with professionals across pathology, laboratory operations, and industry leadership. Structured surveys and senior analyst validation ensure rigor, accuracy, and reliable insight for informed decision-making.

Why This Report Matters

  • Provides strategic clarity for senior executives on market shifts, technology adoption, and operational imperatives in the anatomic pathology sector.
  • Delivers segment-specific and regional intelligence, equipping leaders to craft adaptive strategies that address distinct healthcare delivery, resource, and regulatory contexts.
  • Supports risk mitigation through practical analysis of procurement, supply chain, and reimbursement dynamics relevant to current and emerging market environments.

Conclusion

As anatomic pathology testing evolves at the intersection of digital, molecular, and operational innovation, this report empowers decision-makers to navigate complexity, drive transformation, and realize opportunity in a competitive landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of AI-driven digital pathology platforms for remote diagnostic collaboration
5.2. Development of multiplex immunohistochemistry assays for comprehensive tumor profiling
5.3. Emergence of liquid biopsy integration with histopathology workflows for early cancer detection
5.4. Regulatory approvals driving the commercialization of AI pathology tools for precision medicine
5.5. Standardization of digital slide scanning protocols to improve cross-institutional data compatibility
5.6. Implementation of cloud-based pathology information systems to streamline lab operations
5.7. Emerging trend of AI-enabled predictive biomarkers for personalized oncology treatment planning
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Anatomic Pathology Testing Market, by Test Type
8.1. Introduction
8.2. Digital Pathology
8.2.1. Image Analysis Software
8.2.2. Slide Scanners
8.3. Hematoxylin And Eosin Staining
8.4. Immunohistochemistry
8.4.1. Monoclonal Antibody
8.4.2. Polyclonal Antibody
8.5. Molecular Pathology
8.5.1. Fluorescence In Situ Hybridization
8.5.2. Next Generation Sequencing
8.5.3. Polymerase Chain Reaction
8.6. Special Staining
8.6.1. Periodic Acid-Schiff Stain
8.6.2. Silver Stain
8.6.3. Trichrome Stain
9. Anatomic Pathology Testing Market, by Sample Type
9.1. Introduction
9.2. Cytology Samples
9.3. Frozen Sections
9.4. Tissue Biopsy
10. Anatomic Pathology Testing Market, by Application
10.1. Introduction
10.2. Genetic Disorders
10.2.1. Chromosomal Disorders
10.2.2. Single Gene Disorders
10.3. Infectious Diseases
10.3.1. Bacterial Infections
10.3.2. Viral Infections
10.4. Oncology
10.4.1. Breast Cancer
10.4.2. Lung Cancer
10.4.3. Prostate Cancer
11. Anatomic Pathology Testing Market, by End User
11.1. Introduction
11.2. Diagnostic Laboratories
11.3. Hospitals
11.4. Research Institutes
12. Americas Anatomic Pathology Testing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Anatomic Pathology Testing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Anatomic Pathology Testing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Laboratory Corporation of America Holdings
15.3.2. Quest Diagnostics Incorporated
15.3.3. Sonic Healthcare Limited
15.3.4. Eurofins Scientific SE
15.3.5. SYNLAB Holding GmbH
15.3.6. Unilabs AG
15.3.7. Bio-Reference Laboratories, Inc.
15.3.8. ARUP Laboratories, Inc.
15.3.9. Dr. Lal PathLabs Limited
15.3.10. Metropolis Healthcare Limited
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ANATOMIC PATHOLOGY TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ANATOMIC PATHOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. ANATOMIC PATHOLOGY TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. ANATOMIC PATHOLOGY TESTING MARKET: RESEARCHAI
FIGURE 24. ANATOMIC PATHOLOGY TESTING MARKET: RESEARCHSTATISTICS
FIGURE 25. ANATOMIC PATHOLOGY TESTING MARKET: RESEARCHCONTACTS
FIGURE 26. ANATOMIC PATHOLOGY TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ANATOMIC PATHOLOGY TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SLIDE SCANNERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SLIDE SCANNERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HEMATOXYLIN AND EOSIN STAINING, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HEMATOXYLIN AND EOSIN STAINING, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY POLYCLONAL ANTIBODY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY POLYCLONAL ANTIBODY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY PERIODIC ACID-SCHIFF STAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY PERIODIC ACID-SCHIFF STAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SILVER STAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SILVER STAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TRICHROME STAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TRICHROME STAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY CYTOLOGY SAMPLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY CYTOLOGY SAMPLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY FROZEN SECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY FROZEN SECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY CHROMOSOMAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY CHROMOSOMAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SINGLE GENE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SINGLE GENE DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 141. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 142. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 143. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 144. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 145. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 146. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 147. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 148. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 149. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2024 (USD MILLION)
TABLE 150. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2025-2030 (USD MILLION)
TABLE 151. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 152. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 153. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 156. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 157. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 158. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 159. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 160. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 161. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 164. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 165. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 166. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 167. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 168. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 169. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 170. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 171. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2024 (USD MILLION)
TABLE 172. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2025-2030 (USD MILLION)
TABLE 173. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 174. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 175. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 178. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 179. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 180. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 181. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 182. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 183. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 276. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 277. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 278. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 279. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 280. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 281. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 282. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 283. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2024 (USD MILLION)
TABLE 284. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2025-2030 (USD MILLION)
TABLE 285. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 286. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 287. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 288. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 289. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 290. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 291. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 292. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 293. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 294. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 295. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 298. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 299. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 300. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 301. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 302. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 303. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 304. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 305. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2024 (USD MILLION)
TABLE 306. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2025-2030 (USD MILLION)
TABLE 307. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 308. FRANCE ANATOMIC PATHOLOGY TESTING MARKET S

Samples

Loading
LOADING...

Companies Mentioned

  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • Sonic Healthcare Limited
  • Eurofins Scientific SE
  • SYNLAB Holding GmbH
  • Unilabs AG
  • Bio-Reference Laboratories, Inc.
  • ARUP Laboratories, Inc.
  • Dr. Lal PathLabs Limited
  • Metropolis Healthcare Limited

Table Information

Report AttributeDetails
No. of Pages183
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 47.92 Billion
Forecasted Market Value ( USD ) by 2030 $ 64.78 Billion
Compound Annual Growth Rate6.2%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Anatomic Pathology Market by Product (Instruments, Reagents & Consumables, Services), Technology (Digital Pathology, Immunohistochemistry, In Situ Hybridization), Application, End User - Global Forecast 2025-2030 - Product Image

Anatomic Pathology Market by Product (Instruments, Reagents & Consumables, Services), Technology (Digital Pathology, Immunohistochemistry, In Situ Hybridization), Application, End User - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Anatomic Pathology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Anatomic Pathology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Anatomic Pathology Market Size and Forecasts 2020-2030: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product; Application; and End-User - Product Image

Anatomic Pathology Market Size and Forecasts 2020-2030: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product; Application; and End-User

  • Report
  • 112 Pages
  • Global
From
Anatomic Pathology Track & Trace Solution Market by Product Type (Barcoding Solutions, Integrated Software Platforms, RFID Solutions), Deployment Mode (Cloud-Based, On-Premise), Distribution Channel, Application, End User - Global Forecast 2025-2030 - Product Image

Anatomic Pathology Track & Trace Solution Market by Product Type (Barcoding Solutions, Integrated Software Platforms, RFID Solutions), Deployment Mode (Cloud-Based, On-Premise), Distribution Channel, Application, End User - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Anatomic Pathology Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend and Growth Opportunity Analysis Report Coverage: By Product and Services, Application, End User and Geography - Product Image

Anatomic Pathology Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend and Growth Opportunity Analysis Report Coverage: By Product and Services, Application, End User and Geography

  • Report
  • 178 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.